The upregulation of macrophage migration inhibitory factor (MIF) may be an early event of cancer progression: in fact, markedly higher levels of this cytokine were detected from plasma exosomes of stage I PDAC patients who later developed liver metastasis compared with patients whose pancreatic tumor did not progress [38]. This evidence concerns the gene MIF and cancer.